Skip to main content
. Author manuscript; available in PMC: 2009 Feb 2.
Published in final edited form as: Cereb Cortex. 2007 Feb 13;17(11):2733–2743. doi: 10.1093/cercor/bhl183

Figure 1.

Figure 1

Diagram of the clinical trial. Most common basis for excluding prospective subjects was insufficient hallucination frequency (N = 27). Black rectangle () represents a single, 16-min, 1-Hz rTMS (or sham) session. HCS, Hallucination change score. Open-label phase not reflected in figure.